Stem Cell Applications in Biliary Atresia Patients

Key facts

Sponsor

Necmi Kadıoğlu Hospital

Principal Investigator

Mustafa Azizoglu, MD, PhD

Esenyurt State Hospital

Intervention

Stem Cell(drug)

Enrollment

64 target

Eligibility

18 years · All sexes

Timeline

2024 – 2026

Study locations (1)

• Esenyurt State Hospital, Istanbul, Istanbul, Turkey (Türkiye)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Isolated biliary atresia

Additional recruiting or active studies for the same condition.

• RECRUITINGEARLY PHASE1NCT07250854
  The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
  University of Alabama at Birmingham
• RECRUITINGNANCT06764082
  Nutritional Intervention for Biliary Atresia
  Tongji Hospital
• ACTIVE NOT RECRUITINGNCT06184971
  Biliary Atresia Research Network Northeast
  Yale University
• RECRUITINGNCT05848310
  Preoperative Serum FGF19 in the Prognosis of Biliary Atresia
  Children's Hospital of Fudan University
• RECRUITINGNANCT05925309
  Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy
  Children's Hospital of Fudan University
• ENROLLING BY INVITATIONPHASE3NCT05426733
  An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia
  Albireo, an Ipsen Company
• RECRUITINGNCT05072626
  High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
  Children's Hospital of Fudan University
• RECRUITINGNANCT04272515
  Molecular Characterization for Understanding Biliary Atresia
  Institut National de la Santé Et de la Recherche Médicale, France

See all trials for Isolated biliary atresia →